CLOROX CO /DE/ Financial Summary

Quick Answer

CLOROX CO /DE/ reported Total Revenue of $7.10 billion for fiscal year 2025.

CLOROX CO /DE/ — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $7.10B
+0.2%
$7.09B
-4.0%
$7.39B
+4.0%
$7.11B
-3.2%
$7.34B
+9.2%
$6.72B
+8.2%
Revenue (ASC 606) $7.10B
+0.2%
$7.09B
-4.0%
$7.39B
+4.0%
$7.11B
-3.2%
$7.34B
+9.2%
$6.72B
+8.2%
Net Income $810.00M
+189.3%
$280.00M
+87.9%
$149.00M
-67.7%
$462.00M
-34.9%
$710.00M
-24.4%
$939.00M
+14.5%
Diluted EPS $6.52
+189.8%
$2.25
+87.5%
$1.20
-67.8%
$3.73
-33.2%
$5.58
-24.2%
$7.36
+16.5%
Total Assets $5.56B
-3.3%
$5.75B
-3.3%
$5.95B
-3.5%
$6.16B
-2.8%
$6.33B
+1.9%
$6.21B
+21.4%
Cash and Equivalents $167.00M
-17.3%
$202.00M
-45.0%
$367.00M
+100.5%
$183.00M
-42.6%
$319.00M
-63.4%
$871.00M
+684.7%
Long-Term Debt $2.48B
+0.1%
$2.48B
+0.2%
$2.48B
+0.1%
$2.47B
-0.4%
$2.48B
-10.6%
$2.78B
+21.6%
Stockholders Equity $321.00M
-2.1%
$328.00M
+49.1%
$220.00M
-60.4%
$556.00M
+35.3%
$411.00M
-54.7%
$908.00M
+62.4%
R&D Expense $121.00M
-4.0%
$126.00M
-8.7%
$138.00M
+4.5%
$132.00M
-11.4%
$149.00M
+2.8%
$145.00M
+6.6%
Gross Profit $3.21B
+5.4%
$3.05B
+4.8%
$2.91B
+14.3%
$2.54B
-20.4%
$3.20B
+4.4%
$3.06B
+12.3%
Shares Outstanding 122.69M
-1.2%
124.20M
+0.3%
123.82M
+0.5%
123.15M
+0.3%
122.78M
-2.7%
126.20M
+0.4%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue December 31, 2025 $1.67B -0.8% +17.1%
Revenue (ASC 606) December 31, 2025 $1.67B -0.8% +17.1%
Net Income December 31, 2025 $157.00M -18.7% +96.2%
Diluted EPS December 31, 2025 $1.29 -16.2% +98.5%
Total Assets December 31, 2025 $5.61B +0.6% +1.5%
Cash and Equivalents December 31, 2025 $227.00M -21.7% +36.7%
Long-Term Debt December 31, 2025 $2.49B +0.1% +0.0%
Stockholders Equity December 31, 2025 -$125.00M -204.9% -468.2%
R&D Expense December 31, 2025 $29.00M -6.5% +3.6%
Gross Profit December 31, 2025 $722.00M -2.2% +21.1%
Shares Outstanding December 31, 2025 120.89M -1.8% -0.7%
  • CLOROX CO /DE/ reported Total Revenue of $7.10 billion for fiscal year 2025.
  • CLOROX CO /DE/ showed an increase of +0.2% in Total Revenue compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Revenue (ASC 606) of $7.10 billion for fiscal year 2025.
  • CLOROX CO /DE/ showed an increase of +0.2% in Revenue (ASC 606) compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Net Income of $810.00 million for fiscal year 2025.
  • CLOROX CO /DE/ showed an increase of +189.3% in Net Income compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Diluted EPS of $6.52 per share for fiscal year 2025.
  • CLOROX CO /DE/ showed an increase of +189.8% in Diluted EPS compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Total Assets of $5.56 billion for fiscal year 2025.
  • CLOROX CO /DE/ showed a decrease of -3.3% in Total Assets compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Cash and Equivalents of $167.00 million for fiscal year 2025.
  • CLOROX CO /DE/ showed a decrease of -17.3% in Cash and Equivalents compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Long-Term Debt of $2.48 billion for fiscal year 2025.
  • CLOROX CO /DE/ showed an increase of +0.1% in Long-Term Debt compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Stockholders Equity of $321.00 million for fiscal year 2025.
  • CLOROX CO /DE/ showed a decrease of -2.1% in Stockholders Equity compared to the prior fiscal year.
  • CLOROX CO /DE/ reported R&D Expense of $121.00 million for fiscal year 2025.
  • CLOROX CO /DE/ showed a decrease of -4.0% in R&D Expense compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Gross Profit of $3.21 billion for fiscal year 2025.
  • CLOROX CO /DE/ showed an increase of +5.4% in Gross Profit compared to the prior fiscal year.
  • CLOROX CO /DE/ reported Shares Outstanding of 122.69 million shares for fiscal year 2025.
  • CLOROX CO /DE/ showed a decrease of -1.2% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment